Cost-Effectiveness of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease from Chinese Healthcare Perspective
Crossref DOI link: https://doi.org/10.1007/s12325-022-02372-2
Published Online: 2022-11-12
Published Print: 2023-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xie, Wenwen
Song, Yinyin
Qin, Xiaomei
Jin, Pengfei
Text and Data Mining valid from 2022-11-12
Version of Record valid from 2022-11-12
Article History
Received: 20 September 2022
Accepted: 24 October 2022
First Online: 12 November 2022